Terms: = Prostate cancer AND SSX2, HD21, 6757, ENSG00000157950, SSX, HOM-MEL-40, MGC3884, MGC15364, MGC119055, RP11-552J9_2
61073 results:
1. The Experience of cancer-Related Cognitive Impairment Across Common cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract] [Full Text] [Related]
2. International Variations in Surgical Quality of Care in Men With prostate cancer: Results From the TrueNTH Global Registry.
Sibert NT; Garin O; Ferrer M; Connor SE; Graham ID; Litwin MS; Millar J; Moore CM; Nguyen AV; Paich K; Kowalski C
JCO Glob Oncol; 2024 May; 10():e2300420. PubMed ID: 38815192
[TBL] [Abstract] [Full Text] [Related]
3. Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).
Parker LA; Caballero-Romeu JP; Chilet-Rosell E; Hernandez-Aguado I; Gómez-Pérez L; Alonso-Coello P; Cebrián A; López-Garrigós M; Moral-Pélaez I; Ronda E; Gilabert M; Canelo-Aybar C; Párraga-Martínez I; Del Campo-Giménez M; Lumbreras B
PLoS One; 2024; 19(5):e0303203. PubMed ID: 38814917
[TBL] [Abstract] [Full Text] [Related]
4. Comparative analysis of treatment decision-making in patients with localized prostate and cervical cancer: what influences receiving surgery or radiotherapy?
Minamitani M; Katano A; Mukai T; Ohira S; Nakagawa K
Support Care Cancer; 2024 May; 32(6):391. PubMed ID: 38806815
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
[TBL] [Abstract] [Full Text] [Related]
6. Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries: Baseline data from the DIAdIC study.
Matthys O; Dierickx S; Van Goethem V; Deliens L; Lapeire L; De Pauw A; Hudson P; Vulsteke C; Geboes K; De Waele S; Spoormans I; Di Leo S; Guberti M; Schmidt US; Scott D; Harding R; Witkamp E; Connolly M; ; De Vleminck A; Cohen J
Psychooncology; 2024 Jun; 33(6):e6347. PubMed ID: 38804579
[TBL] [Abstract] [Full Text] [Related]
7. Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high-volume center in Southeast China.
Lin S; Jiang W; Ding J; Hao S; Chen H; Xie L; Zheng X
World J Surg Oncol; 2024 May; 22(1):140. PubMed ID: 38802859
[TBL] [Abstract] [Full Text] [Related]
8. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract] [Full Text] [Related]
9. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy.
Wang B; Pan J; Zhang T; Ni X; Wei Y; Li X; Fang B; Hu X; Gan H; Wu J; Wang H; Ye D; Zhu Y
BMC Cancer; 2024 May; 24(1):643. PubMed ID: 38796422
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
[TBL] [Abstract] [Full Text] [Related]
11. The impact of low pressure pneumoperitoneum in robotic assisted radical prostatectomy II: a prospective, randomized, double blinded trial.
Keating K; Holdren C; Eames R; Pulford C; O'Pry E; Peifer D; Rohloff M; Fletcher J; Maatman TJ
World J Urol; 2024 May; 42(1):347. PubMed ID: 38789638
[TBL] [Abstract] [Full Text] [Related]
12. Relationship between Femoral Proximal Bone Quality Assessment by MRI IDEAL-IQ Sequence and Body Mass Index in Elderly Men.
Goto K; Watanabe D; Kawae N; Nakamura T; Yanagida K; Yoshida T; Kajihara H; Mizushima A
Tomography; 2024 May; 10(5):816-825. PubMed ID: 38787022
[TBL] [Abstract] [Full Text] [Related]
13. Novel Metabolites from the Marine-Derived Fungus
Yang B; Shao S; Nie M; Tie Q; Pang X; Lin X; Zhou X; Liu Y; Wang X; Li Y
Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786609
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic Potential of Hydrogen Sulfide in Reproductive System Disorders.
Sun X; Mao C; Xie Y; Zhong Q; Zhang R; Jiang D; Song Y
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785947
[TBL] [Abstract] [Full Text] [Related]
15. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
Longo CJ; Maity T; Fitch MI; Young JT
Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
[TBL] [Abstract] [Full Text] [Related]
16. Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of prostate cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation.
Potkrajcic V; Gani C; Fischer SG; Boeke S; Niyazi M; Thorwarth D; Voigt O; Schneider M; Mönnich D; Kübler S; Boldt J; Hoffmann E; Paulsen F; Mueller AC; Wegener D
Curr Oncol; 2024 May; 31(5):2679-2688. PubMed ID: 38785484
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis.
Cui F; Tang X; Man C; Fan Y
BMC Cancer; 2024 May; 24(1):628. PubMed ID: 38783246
[TBL] [Abstract] [Full Text] [Related]
18. The association between three prevalent autoimmune disorders and the likelihood of developing prostate cancer: a Mendelian randomization study.
Deng X; Sun S; Yao W; Yue P; Guo F; Wang Y; Zhang Y
Sci Rep; 2024 May; 14(1):11755. PubMed ID: 38783043
[TBL] [Abstract] [Full Text] [Related]
19. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
[TBL] [Abstract] [Full Text] [Related]
20. Effectiveness of educational and psychological survivorship interventions to improve health-related quality of life outcomes for men with prostate cancer on androgen deprivation therapy: a systematic review.
Sara SA; Heneka N; Green A; Chambers SK; Dunn J; Terry VR
BMJ Open; 2024 May; 14(5):e080310. PubMed ID: 38777593
[TBL] [Abstract] [Full Text] [Related]
[Next]
